Genes identified as up- or down-regulated in multiple sclerosis in at least three studies
| Gene | Description | Direction of change in expression in multiple sclerosis |
| ATP7A | ATPase, Cu2+ transporting, alpha polypeptide | Decreased (FIN11 15 16) |
| CCL3 | Chemokine (C-C motif) ligand 3 | Decreased11–13 |
| CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Decreased (FIN9 11) |
| HSPA1A | Heat shock 70 kDa protein 1A | Decreased9 12 13 15 16 |
| PLAUR | Plasminogen activator, urokinase receptor | Decreased11–13 |
| EIF4A1 | Eukaryotic translation initiation factor 4A1 | Increased (FIN9 11) |
| NEAT1 | Nuclear paraspeckle assembly transcript 1 (non-protein coding) | Increased (FIN9 11) |
| OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | Increased (FIN11 12) |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclo-oxygenase) | Increased11–13 |
| RBBP6 | Retinoblastoma-binding protein 6 | Increased (FIN9 11) |
| TNFAIP3 | Tumour necrosis factor, alpha-induced protein 3 | Increased (FIN11 15 16) |
| ZMYND8 | Zinc finger, MYND-type containing 8 | Increased (FIN11 12) |
FIN, previously unpublished Finnish microarray screen described in detail here.